Home
Full Prescribing Information

IMPORTANT SAFETY INFORMATION

FINACEA is for dermatologic use only, and not for ophthalmic, oral, or intravaginal use.
FINACEA is contraindicated in individuals with a history of hypersensitivity to propylene glycol or any other component of the formulation. In clinical trials, sensations of burning/stinging/tingling occurred in 29% of patients, and itching in 11%, regardless of the relationship to therapy. Continue reading below

>> Bayer Group
A quick, convenient routine to help you take control of managing the bumps, pimples and associated redness of your mild to moderate rosacea.
Learn more


Skincare Porduct

To help you develop a skin-care routine that's right for you, we've included 2 selected lists of premium skin-care products recommended by Dr. Leslie Baumann, Professor of Dermatology at the University of Miami.

Cleansers
Aveeno® Ultra-Calming Foaming Cleanser
Dove® Sensitive Skin Beauty bar
Eucerin® Redness Relief Soothing Cleanser

Sun Protection (for morning routine)
Aveeno® Ultra-Calming Daily Moisturizer with SPF 15
Eucerin® Sensitive Facial Skin Extra Protective Moisture Lotion with SPF 30

SOURCE: Dr. Leslie Baumann

Find a dermatologist
Find a dermatologist

 
Tell-a-friend about MyFinacea.com
Already using FINACEA?

INDICATIONS & USAGE

FINACEA is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. Although some reduction of erythema, which was present in patients with papules and pustules of rosacea, occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated.

IMPORTANT SAFETY INFORMATION

FINACEA is for dermatologic use only, and not for ophthalmic, oral, or intravaginal use. FINACEA is contraindicated in individuals with a history of hypersensitivity to propylene glycol or any other component of the formulation. In clinical trials, sensations of burning/stinging/tingling occurred in 29% of patients, and itching in 11%, regardless of the relationship to therapy. Post-marketing safety - Skin: facial burning and irritation; Eyes: iridocyclitis on accidental exposure to the eye. There have been isolated reports of hypopigmentation after use of azelaic acid. Since azelaic acid has not been well studied in patients with a dark complexion, these patients should be monitored for early signs of hypopigmentation.

Other than FINACEA, Intendis, Inc. (part of the Bayer group) does not promote or endorse any products or recommendations made by third parties. All products and brand names listed are the property and responsibility of their respective trademark and copyright holders.

Please see full prescribing information for FINACEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.




Copyright (C) Bayer AG